Analyst Ratings for Rigel Pharmaceuticals (RIGL) [Buys]

RIGL Rating Summary

RIGL Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RIGL
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $5.00 (+76.7%) * Over Last 12-Mos
Rating Score: 3 / 10   Percentile Rank: 27%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
4/22/2016 JPMorgan Upgrade Overweight
(Neutral)
5.00
(N/A)
2.49 2.83 13.65% Details
3/31/2015 Jefferies New Coverage Buy
(N/A)
10.00
(N/A)
3.35 2.83 -15.52% Details